The hCG Institute is dedicated to helping people combat obesity using human chorionic gonadotropin (hCG). This hormone was first attributed to weight loss by the physician A.T.W. Simeons in his now famous HCG Protocol; Pounds and Inches, A New Approach to Obesity. It was in this documentation that he outlined his discovery and methodology for treating the obesity disorder with hCG. He found that a low dosage of a hormone that occurs in women during pregnancy, that which was used to treat gonadal disorders in young boys drastically reduces the abnormal fat tissue in obese patients.
Of the three types of fat that are distinguishable in the human body, Simeons claimed that Chorionic Gonadotropin attacks the “abnormal fat” accumulation that afflicts a typical overweight patient. When an obese patient attempts to starve themselves in an attempt to lose weight the abnormal fat is not used by the body for fuel. During a nutritional emergency the body begins to burn the normal fat reserve and only after the structural fat is exhausted will the body turn to the abnormal fat tissues to account for the nutritional deficit. It is at this point that a starved patient will typically experience weakness and severe hunger while the abnormal fat has not even begun to burn.
However, there is one such nutritional emergency where all of the bodies fat tissue become available as fuel; pregnancy. During gestation the abnormal fat cells are available to the fetus and Dr. Simeons suggests that the large quantities of hCG during pregnancy incite these changes in the hypothalamus.
How do we know that HCG is effective?
The HCG Institute and our parent practice have successfully treated thousands of patients with hCG over the past 9 years and have come to the same conclusions. Safe, effective and easy. Patients who strictly follow a 500-900 calorie diet while administering their daily dosage of injections or prescription sublingual drops experience significant weight loss. Furthermore, a large segment of those patients experience weight loss in the abnormal fat deposits that occur around the hips, thighs, belly and underarms.
American physician Harry A. Gusman M.D. outlined his experiences with the hCG hormone for weight loss (2). In 2500 patients between the ages of 15 to 75, responses to daily questioning and weight loss results among patients were consistent with the views of Dr. Simeons. In his article for the American Journal of Clinical Nutrition he states; “My own early skepticism of the method quickly dissipated after I had an opportunity to observe Dr. Simeons’ work at his clinic in Rome. Since that time, experience has shown his method to be not only the most scientific approach to the problem but also the safest and most productive.”
How can we be certain that HCG is safe?
Consider that hCG is present and in large amounts during pregnancy, which is the most important stage of human development. It exists in the mother and in the fetus and without any negative effect to any organ system of either the mother or the fetus where upwards of 1,000,000 units can be excreted per day. As such, the dosage of 125 to 250 units per day of the treatment is completely safe.
Obesity is the disease caused when the intake of calories as food is greater than the expenditure of calories as energy. The only way to combat obesity is to counter this cycle. An intake of 500 calories per day will guarantee that your body will burn off the extra calories throughout the day and the hCG will help maintain your low appetite levels and stimulate your body to burn off the abnormal fat.
Visit Start hCG Now or call 1 877-228-2158 if you or someone you know is struggling with obesity. We can help.
- Simeons ATW. The action of chorionic gonadotropin in the obese. Lancet 1954; ii: 946-947
- Chorionic Gonadotropin in Obesity: Further Clinical Observations, Gusman Harry A,. American Journal of Clinical Nutrition 1969, ii: 686-695
- Current and Potential Drugs for Treatment of Obesity George A. Bray and Frank L. Greenway Endocrine Reviews 20 (6): 805-875
- Chorionic Gonadotropin in Weight Control: A Double-Blind Crossover Study, Lt Col Robert L. Young, Robert J. Fuchs, Myron J. Woltjen. JAMA. 1976;236(22):2495-2497.